@Article{Figurska2010,
journal="Klinika Oczna / Acta Ophthalmologica Polonica",
issn="0023-2157",
volume="112",
number="3",
year="2010",
title="Złożone leczenie wysiękowej postaci zwyrodnienia plamki związanego z wiekiem",
abstract="Purpose: Therapeutic options in active exudative age-related macular degeneration (AMD) are following means used to destroy   the choroidal neovascularization (CNV) lesion: laser photocoagulation, radiotherapy, transpupillary thermotherapy, photodynamic   therapy (PDT) or removal of neovascular membrane through vitreoretinal surgery. Another possibility is to suppress the development of neovascularization through intravitreal administration of anti-VEGF agents: ranibizumab, bevacizumab (off-label), sodium   pegaptanib or steroids (off-label).  The aim of this paper is to present the early phase of treating exudative AMD with combined therapy: photodynamic therapy   with intravitreal ranibizumab injection.  Material and methods: Our observation is based on three clinical cases. Observations are being carried out on larger patient   groups according to the treatment scheme presented in this paper.  Results: In the three cases described one PDT procedure and the saturation phase of three ranibizumab injections allowed   a significant improvement in visual acuity and closure of CNV leakage confirmed by fluorescein angiography (FA) and optical coherence tomography (OCT). Treatment is being continued according to AMD activity: next PDT in case of leakage in FA, another   ranibizumab injection according to PRONTO study reinjection criteria.  Conclusions: The pathomechanism of exudative AMD confirms reasonability of combined treatment. Considering the stages of   neovascularization in exudative AMD, VEGF inhibition combined with PDT has a synergistic action and increases the effectiveness of both therapies alone. Large clinical studies (FOCUS) show that combined therapy reduces the number or required PDT   procedures. In combined therapy modification of PDT parameters should be considered: reduction of energy and laser exposure   time.",
author="Figurska, Małgorzata
and Wierzbowska, Joanna
and Robaszkiewicz, Jacek",
pages="223--229",
url="https://www.termedia.pl/Combined-therapy-in-exudative-age-related-r-nmacular-degeneration,124,48621,1,1.html"
}